Skip to search formSkip to main contentSkip to account menu

Kit Dosage Form

Known as: Kit, Kit Dose Form 
A collection of unrelated materials that are used together to orchestrate dosage administration.
National Institutes of Health

Related topics

Related topics

3 relations
CDISC SDTM Pharmaceutical Dosage Form TerminologyClinical Data Interchange Standards Consortium TerminologyStructured Product Labeling Pharmaceutical Dosage Form Terminology

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
Prognostic Significance of KIT Mutations in Core-Binding Factor Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis
The prognostic significance of KIT mutations in core-binding factor acute myeloid leukemia (CBF-AML), including inv(16) and t(8… 
Highly Cited
2014
Highly Cited
2014
Mutually exclusive mutations of KIT and RAS are associated with KIT mRNA expression and chromosomal instability in primary intracranial pure germinomas
Intracranial germ cell tumors (iGCTs) are the second most common brain tumors among children under 15 in Japan. The pathogenesis… 
Highly Cited
2013
Highly Cited
2013
The importance of relative mutant level for evaluating impact on outcome of KIT, FLT3 and CBL mutations in core-binding factor acute myeloid leukemia
Several different mutations collaborate with the fusion proteins in core-binding factor acute myeloid leukemia (CBF-AML) to… 
Highly Cited
2012
Highly Cited
2012
Prognostic value of KIT/PDGFRA mutations in gastrointestinal stromal tumours (GIST): Polish Clinical GIST Registry experience.
BACKGROUND Majority of gastrointestinal stromal tumours (GISTs) are characterised by KIT-immunopositivity and the presence of KIT… 
Review
2011
Review
2011
Association of Merkel cell polyomavirus infection with tumor p53, KIT, stem cell factor, PDGFR‐alpha and survival in Merkel cell carcinoma
Most Merkel cell carcinomas (MCCs) contain Merkel cell polyomavirus (MCPyV) DNA, and the virus likely has a pivotal role in tumor… 
Highly Cited
2008
Highly Cited
2008
Silent mutations in KIT and PDGFRA and coexpression of receptors with SCF and PDGFA in Merkel cell carcinoma: implications for tyrosine kinase-based tumorigenesis
Merkel cell carcinoma is a rare and aggressive form of skin cancer of neuroendocrine origin. Its treatment involves wide excision… 
Highly Cited
2008
Highly Cited
2008
The analysis of status and clinical implication of KIT and PDGFRA mutations in gastrointestinal stromal tumor (GIST)
to analyze the frequency and spectrum of KIT and platelet‐derived growth factor receptor‐alpha (PDGFRA) gene in a large series of… 
Highly Cited
2003
Highly Cited
2003
Resistance and perspectives in soft tissue sarcomas
Postradiation sarcoma, a sarcoma developing in a previously irradiated field, is a rare tumor. Surgery appears to be the only… 
Highly Cited
2003
Highly Cited
2003
Expression of KIT and epidermal growth factor receptor in chemotherapy refractory non-seminomatous germ-cell tumors.
BACKGROUND The majority of patients with germ-cell tumors (GCTs) are curable with standard therapy. The molecular differences… 
Highly Cited
2003
Highly Cited
2003
Clinicopathological analysis of c-kit expression in carcinosarcomas and leiomyosarcomas of the uterine corpus.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)